Amgen Inc. (NASDAQ:AMGN) Shares Acquired by Carnegie Investment Counsel

Carnegie Investment Counsel boosted its holdings in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.8% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 99,420 shares of the medical research company’s stock after purchasing an additional 3,660 shares during the quarter. Amgen […]

Leave a Reply

Your email address will not be published.

Previous post Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded to “Sell” at StockNews.com
Next post Carnegie Investment Counsel Boosts Stake in The Home Depot, Inc. (NYSE:HD)